• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状RNA circLRCH3通过miRNA-223/LPP轴抑制结肠癌细胞的增殖、迁移和侵袭。

Circular RNA circLRCH3 Inhibits Proliferation, Migration, and Invasion of Colorectal Cancer Cells Through miRNA-223/LPP Axis.

作者信息

Yang Yiming, Wang Di, Tao Kaixiong, Wang Guobin

机构信息

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430033, People's Republic of China.

出版信息

Onco Targets Ther. 2022 May 18;15:541-554. doi: 10.2147/OTT.S366605. eCollection 2022.

DOI:10.2147/OTT.S366605
PMID:35611368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9124491/
Abstract

PURPOSE

Colorectal cancer (CRC) is one of the most common carcinomas worldwide with a high mortality rate. Numerous studies suggest that circular RNA (circRNA) plays a crucial role in the progression of various carcinomas, including CRC. The present work focused on exploring the role and underlying molecular mechanism of action of the circRNA circLRCH3 in CRC.

METHODS

Real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was conducted to detect expression levels of circLRCH3, miR-233, and lipoma preferred partner (LPP). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to measure the proliferation of CRC cells and the transwell assay was used to evaluate cell migration and invasion capacity. A flow cytometry assay was used to analyze the effect of circLRCH3 on the distribution of the cell cycle and apoptosis of CRC cells. The expression of LPP was analyzed using Western blotting or an RT-qPCR assay. The relationship between miR-223 and circLRCH3, and that between miR-223 and LPP, was predicted and examined using bioinformatics analysis and luciferase reporter gene experiments. A xenograft tumor formation assay was also performed.

RESULTS

We found that the expression level of circLRCH3 was downregulated in CRC cells and negatively correlated with miR-223. The overexpression of circLRCH3 or silencing of miR-223 inhibited the growth, invasion, and migration of CRC cells, but promoted their apoptosis. In contrast, overexpression of miR-223 and depletion of LPP severally abrogated the tumor suppressive roles of circLRCH3 and miR-223 knockdown in CRC cells in vitro. The xenograft experiments in nude mice also proved the antitumor effect of circLRCH3.

CONCLUSION

These results suggested that the circLRCH3/miR-223/LPP axis likely plays a critical role in CRC.

摘要

目的

结直肠癌(CRC)是全球最常见的癌症之一,死亡率很高。大量研究表明,环状RNA(circRNA)在包括CRC在内的各种癌症进展中起关键作用。本研究重点探讨环状RNA circLRCH3在CRC中的作用及其潜在的分子作用机制。

方法

采用实时逆转录定量聚合酶链反应(RT-qPCR)检测circLRCH3、miR-223和脂肪瘤优先伴侣(LPP)的表达水平。采用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法检测CRC细胞的增殖情况,采用Transwell法评估细胞迁移和侵袭能力。采用流式细胞术分析circLRCH3对CRC细胞周期分布和凋亡的影响。采用蛋白质免疫印迹法或RT-qPCR法分析LPP的表达。使用生物信息学分析和荧光素酶报告基因实验预测并检测miR-223与circLRCH3之间以及miR-223与LPP之间的关系。还进行了异种移植肿瘤形成实验。

结果

我们发现,circLRCH3在CRC细胞中的表达水平下调,且与miR-223呈负相关。circLRCH3的过表达或miR-223的沉默抑制了CRC细胞的生长、侵袭和迁移,但促进了它们的凋亡。相反,miR-223的过表达和LPP的缺失分别消除了circLRCH3和miR-223敲低在体外对CRC细胞的肿瘤抑制作用。裸鼠异种移植实验也证明了circLRCH3的抗肿瘤作用。

结论

这些结果表明,circLRCH3/miR-223/LPP轴可能在CRC中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/94e94d72ca29/OTT-15-541-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/c2dd10bcbe56/OTT-15-541-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/0d0930924ee6/OTT-15-541-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/652762c7740b/OTT-15-541-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/5a6deac3f7a8/OTT-15-541-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/9689589840f4/OTT-15-541-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/94e94d72ca29/OTT-15-541-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/c2dd10bcbe56/OTT-15-541-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/0d0930924ee6/OTT-15-541-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/652762c7740b/OTT-15-541-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/5a6deac3f7a8/OTT-15-541-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/9689589840f4/OTT-15-541-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe5/9124491/94e94d72ca29/OTT-15-541-g0006.jpg

相似文献

1
Circular RNA circLRCH3 Inhibits Proliferation, Migration, and Invasion of Colorectal Cancer Cells Through miRNA-223/LPP Axis.环状RNA circLRCH3通过miRNA-223/LPP轴抑制结肠癌细胞的增殖、迁移和侵袭。
Onco Targets Ther. 2022 May 18;15:541-554. doi: 10.2147/OTT.S366605. eCollection 2022.
2
Circular RNA circLRCH3 promotes oxaliplatin resistance in gastric cancer through the modulation of the miR-383-5p/FGF7 axis.环状 RNA circLRCH3 通过调节 miR-383-5p/FGF7 轴促进胃癌对奥沙利铂的耐药性。
Histol Histopathol. 2023 Jun;38(6):647-658. doi: 10.14670/HH-18-506. Epub 2022 Aug 3.
3
Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.环状 ACAP2 通过介导 miR-143-3p/FZD4 轴促进结直肠癌的进展。
Eur J Clin Invest. 2021 Dec;51(12):e13607. doi: 10.1111/eci.13607. Epub 2021 Jun 4.
4
Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.环状 RNA circ_0007142 通过 miR-455-5p/SGK1 轴调控结直肠癌中的细胞增殖、凋亡、迁移和侵袭。
Anticancer Drugs. 2021 Jan 1;32(1):22-33. doi: 10.1097/CAD.0000000000000992.
5
Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.环状 RNA 100146 通过 microRNA 149/HMGA2 轴促进结直肠癌进展。
Mol Cell Biol. 2021 Jan 25;41(2). doi: 10.1128/MCB.00445-20.
6
Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.转录因子 SP1 诱导的 microRNA-146b-3p 通过调节 FAM107A 促进结直肠癌的进展和转移。
Life Sci. 2021 Jul 15;277:119398. doi: 10.1016/j.lfs.2021.119398. Epub 2021 Apr 5.
7
Knockdown of circAPLP2 Inhibits Progression of Colorectal Cancer by Regulating miR-485-5p/FOXK1 Axis.环状 RNA 相关蛋白 2 敲低通过调控 miR-485-5p/叉头框蛋白 K1 轴抑制结直肠癌的进展。
Cancer Biother Radiopharm. 2021 Nov;36(9):737-752. doi: 10.1089/cbr.2019.3310. Epub 2020 Apr 24.
8
CircRNA_0084927 promotes colorectal cancer progression by regulating miRNA-20b-3p/glutathione S-transferase mu 5 axis.环状 RNA_0084927 通过调控 miRNA-20b-3p/谷胱甘肽 S-转移酶 mu5 轴促进结直肠癌的进展。
World J Gastroenterol. 2021 Sep 28;27(36):6064-6078. doi: 10.3748/wjg.v27.i36.6064.
9
Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.环状 RNA hsa_circRNA_102209 通过 miR-761 介导的 Ras 和 Rab 相互作用蛋白 1 信号促进结直肠癌细胞的生长和转移。
Cancer Med. 2020 Sep;9(18):6710-6725. doi: 10.1002/cam4.3332. Epub 2020 Jul 24.
10
CircCSNK1G1 Contributes to the Development of Colorectal Cancer by Increasing the Expression of MYO6 via Competitively Targeting miR-455-3p.环状CSNK1G1通过竞争性靶向miR-455-3p增加MYO6的表达,从而促进结直肠癌的发展。
Cancer Manag Res. 2020 Oct 2;12:9563-9575. doi: 10.2147/CMAR.S262007. eCollection 2020.

引用本文的文献

1
Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.非编码RNA与结直肠癌程序性细胞死亡之间的相互作用:对靶向治疗的启示
Epigenetics Chromatin. 2025 Jan 15;18(1):3. doi: 10.1186/s13072-024-00560-8.
2
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.miR-223-3p 在癌症发生发展和癌症药物耐药中的作用:同一枚硬币,两面不同。
Int J Mol Sci. 2024 Jul 26;25(15):8191. doi: 10.3390/ijms25158191.
3
Transcriptional Dysregulations of Seven Non-Differentially Expressed Genes as Biomarkers of Metastatic Colon Cancer.

本文引用的文献

1
circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.环状 RNA MRPS35 促进肝癌的恶性进展和顺铂耐药性。
Mol Ther. 2022 Jan 5;30(1):431-447. doi: 10.1016/j.ymthe.2021.08.027. Epub 2021 Aug 25.
2
Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling.环状 RNA 编码的致癌性 E-钙黏蛋白变体通过激活 EGFR-STAT3 信号通路促进胶质母细胞瘤的致瘤性。
Nat Cell Biol. 2021 Mar;23(3):278-291. doi: 10.1038/s41556-021-00639-4. Epub 2021 Mar 4.
3
Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation.
七种非差异表达基因转录失调作为转移性结直肠癌的生物标志物。
Genes (Basel). 2023 May 24;14(6):1138. doi: 10.3390/genes14061138.
CCT-3的上调通过miR-223竞争和Wnt/β-连环蛋白信号通路激活诱导乳腺癌细胞增殖。
Front Oncol. 2020 Sep 24;10:533176. doi: 10.3389/fonc.2020.533176. eCollection 2020.
4
Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance.环状 RNA 在癌症中的作用:生物发生、功能和临床意义。
Trends Cancer. 2020 Apr;6(4):319-336. doi: 10.1016/j.trecan.2020.01.012. Epub 2020 Feb 19.
5
Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma.miRNA-154-5p 的上调可预防骨肉瘤的发生。
Biomed Pharmacother. 2020 Apr;124:109884. doi: 10.1016/j.biopha.2020.109884. Epub 2020 Jan 27.
6
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.miRNA 表达变化在新辅助贝伐珠单抗和化疗治疗乳腺癌过程中。
Mol Oncol. 2019 Oct;13(10):2278-2296. doi: 10.1002/1878-0261.12561. Epub 2019 Aug 28.
7
The biogenesis, biology and characterization of circular RNAs.环状 RNA 的生物发生、生物学和特征。
Nat Rev Genet. 2019 Nov;20(11):675-691. doi: 10.1038/s41576-019-0158-7. Epub 2019 Aug 8.
8
Construction of a circRNA-miRNA-mRNA network to explore the pathogenesis and treatment of pancreatic ductal adenocarcinoma.构建 circRNA-miRNA-mRNA 网络探索胰腺导管腺癌的发病机制和治疗方法。
J Cell Biochem. 2020 Jan;121(1):394-406. doi: 10.1002/jcb.29194. Epub 2019 Jun 24.
9
Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway.环状 RNA circβ-catenin 通过激活 Wnt 通路促进肝癌细胞生长。
Genome Biol. 2019 Apr 26;20(1):84. doi: 10.1186/s13059-019-1685-4.
10
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.外泌体 miRNA 谱作为新辅助化疗局部乳腺癌诊断和预测治疗反应的补充工具。
Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0.